Roberto M Lang Selected Research

regadenoson

9/2019	Hemodynamic impact of coronary stenosis using computed tomography: comparison between noninvasive fractional flow reserve and 3D fusion of coronary angiography with stress myocardial perfusion.
1/2018	Fusion of Three-Dimensional Echocardiographic Regional Myocardial Strain with Cardiac Computed Tomography for Noninvasive Evaluation of the Hemodynamic Impact of Coronary Stenosis in Patients with Chest Pain.
6/2017	Non-invasive assessment of the haemodynamic significance of coronary stenosis using fusion of cardiac computed tomography and 3D echocardiography.
12/2013	Prognostic value of normal regadenoson stress perfusion cardiovascular magnetic resonance.
12/2012	Considerations when measuring myocardial perfusion reserve by cardiovascular magnetic resonance using regadenoson.
7/2012	Quantitative three-dimensional evaluation of myocardial perfusion during regadenoson stress using multidetector computed tomography.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roberto M Lang Research Topics

Disease

14	Heart Failure 01/2021 - 07/2009
5	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 09/2003
5	Myocardial Infarction 01/2020 - 12/2013
4	Sarcoidosis (Schaumann Disease) 04/2021 - 11/2011
3	Cardiomyopathies (Cardiomyopathy) 01/2022 - 03/2004
3	Mitral Valve Insufficiency (Mitral Regurgitation) 01/2021 - 04/2009
3	Pathologic Constriction (Stenosis) 09/2019 - 07/2011
3	Chest Pain (Chest Pains) 09/2019 - 06/2017
3	Aortic Valve Stenosis (Aortic Stenosis) 05/2017 - 11/2010
3	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 01/2017 - 04/2014
3	Pulmonary Hypertension 05/2012 - 04/2008
2	Amyloidosis 01/2022 - 11/2016
2	Disease Progression 01/2018 - 09/2008
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2018 - 09/2003
2	Ventricular Tachycardia 11/2016 - 01/2016
2	Ischemic Stroke 10/2016 - 01/2006
2	Infarction (Infarctions) 04/2016 - 07/2013
2	Left Ventricular Dysfunction 05/2014 - 05/2010
2	Pulmonary Arterial Hypertension 01/2014 - 06/2012
2	Hyperemia 12/2013 - 12/2012
2	Hypoxia (Hypoxemia) 04/2012 - 04/2008
2	Coronary Vasospasm (Coronary Artery Vasospasm) 10/2009 - 04/2004
1	Syncope (Fainting) 01/2022
1	Lung Diseases (Lung Disease) 01/2021
1	Mitral Valve Stenosis (Mitral Stenosis) 01/2021
1	Embolism (Embolus) 09/2019
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 04/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Obesity Hypoventilation Syndrome (Pickwickian Syndrome) 01/2018
1	Hematoma 01/2018
1	Acute Chest Syndrome 01/2017
1	Death (Near-Death Experience) 11/2016
1	Transient Ischemic Attack 10/2016
1	Breast Neoplasms (Breast Cancer) 05/2016
1	Thrombosis (Thrombus) 05/2016
1	Pulmonary Embolism 05/2016
1	Ischemia 04/2016
1	Cicatrix (Scar) 04/2016
1	Atherosclerosis 03/2016
1	Hemolysis 01/2016
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2016
1	Iron Overload 05/2014
1	Fibrosis (Cirrhosis) 05/2014
1	Atrial Fibrillation 01/2014
1	Chronic Renal Insufficiency 01/2014
1	Ventricular Remodeling 01/2014
1	Ventricular Heart Septal Defects (Ventricular Septal Defect) 07/2013
1	Cardiogenic Shock 09/2012
1	Cardiac Arrhythmias (Arrythmia) 04/2012
1	Hyperoxia 04/2012
1	Respiratory Insufficiency (Respiratory Failure) 04/2012

Drug/Important Bio-Agent (IBA)

8	GadoliniumIBA 01/2020 - 11/2011
6	regadenoson FDA Link 09/2019 - 07/2012
5	Vasodilator Agents (Vasodilators)IBA 09/2019 - 05/2008
3	Contrast MediaIBA 11/2008 - 09/2002
2	Dobutamine FDA LinkGeneric 01/2017 - 11/2011
2	RNA (Ribonucleic Acid)IBA 05/2016 - 04/2008
2	Aminophylline (Carine)FDA LinkGeneric 12/2013 - 12/2012
2	perflutren (octafluoropropane)FDA Link 05/2012 - 12/2007
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 04/2021
1	Oxidoreductases (Dehydrogenase)IBA 01/2021
1	activin AIBA 01/2018
1	Hemoglobins (Hemoglobin)IBA 01/2017
1	DiureticsIBA 01/2017
1	Angiotensin Receptor AntagonistsIBA 01/2017
1	Amyloid (Amyloid Fibrils)IBA 11/2016
1	Trastuzumab (Herceptin)FDA Link 05/2016
1	4-S-(propionic acid)sulfidocyclophosphamide (PASP)IBA 05/2016
1	A 7 (A-7)IBA 05/2016
1	oxidized low density lipoproteinIBA 03/2016
1	LipidsIBA 03/2016
1	Heme (Haem)IBA 01/2016
1	hemoglobin P (Hb P)IBA 01/2016
1	Interleukin-18 (Interleukin 18)IBA 01/2016
1	Pharmaceutical PreparationsIBA 01/2014
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2014
1	omega-Chloroacetophenone (Mace)IBA 12/2013
1	Particulate MatterIBA 04/2012
1	Ranolazine FDA Link 04/2012
1	Sodium Channels (Sodium Channel)IBA 04/2012

Therapy/Procedure

12	Therapeutics 01/2021 - 01/2006
5	Cardiac Resynchronization Therapy 01/2021 - 07/2009
3	Heart-Assist Devices 01/2021 - 05/2010
2	Defibrillators (Defibrillator) 04/2019 - 04/2014
2	Transcatheter Aortic Valve Replacement 05/2017 - 11/2010
2	Catheters 04/2016 - 03/2003
1	Bioprosthesis 01/2021
1	Punctures 09/2019
1	Cardiopulmonary Resuscitation (CPR) 01/2018
1	Noninvasive Ventilation 01/2018
1	Heart Transplantation (Grafting, Heart) 11/2016
1	Septal Occluder Device 10/2016
1	Transplantation 01/2016
1	Blood Transfusion (Blood Transfusions) 05/2014
1	Extracorporeal Membrane Oxygenation 07/2013
1	Denervation 04/2012
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 03/2012
1	Lung Transplantation 02/2012